Literature DB >> 1867298

Clinical patterns and associated conditions in chronic uveitis.

A Weiner1, D BenEzra.   

Abstract

We determined the relative frequencies of the different types of chronic uveitis, and the possible associated conditions, among 400 consecutive patients with chronic uveitis examined during the years 1982 through 1988. Of the 400 patients, 183 (45.75%) had anterior uveitis, 98 (24.5%) ahd panuveitis, 61 (15.3%) had intermediate uveitis, and 58 (14.5%) had isolated posterior uveitis. Only four of the 98 patients with panuveitis (4.1%) were considered idiopathic after a comprehensive examination, whereas 94 of the 183 patients with anterior uveitis (51.4%) were similarly classified. We found an associated condition in 242 of the 400 patients of the study group (60.5%). Of these 242 patients, 61 had Behçet's disease, which constituted the most frequently encountered associated condition in this study. Of the 61 patients with Behçet's disease, 58 had panuveitis and constituted 59.2% of the panuveitis group. Of the 61 patients with intermediate uveitis, 17 (27.9%) had a concurrent disease. An associated condition was found in 95% and 96.2% of patients with unilateral and bilateral panuveitis, respectively, but in none of the patients with unilateral intermediate uveitis. Environmental, cultural, or genetic factors may be accountable for the differences discovered between our findings and those of previously published studies from the United States and England with respect to relative frequencies of some of the associated diseases in patients with chronic uveitis.

Entities:  

Mesh:

Year:  1991        PMID: 1867298     DOI: 10.1016/s0002-9394(14)76694-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

1.  Soluble ICAM-1 serum levels in patients with intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

Review 2.  Management of chronic uveitis.

Authors:  P J McCluskey; H M Towler; S Lightman
Journal:  BMJ       Date:  2000-02-26

Review 3.  Chronic non-infectious uveitis in the elderly: epidemiology, pathophysiology and management.

Authors:  Rajen Gupta; Philip I Murray
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Uveitis in children and adolescents.

Authors:  D BenEzra; E Cohen; G Maftzir
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

5.  Recent Patents on Emerging Therapeutics for the Treatment of Glaucoma, Age Related Macular Degeneration and Uveitis.

Authors:  Aswani Dutt Vadlapudi; Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Recent Pat Biomed Eng       Date:  2012-04-01

6.  Uveitis and juvenile idiopathic arthritis: A cohort study.

Authors:  David BenEzra; Evelyne Cohen; Francine Behar-Cohen
Journal:  Clin Ophthalmol       Date:  2007-12

7.  Tuberculous uveitis.

Authors:  Ahmed M; Abu El-Asrar; Marwan Abouammoh; Hani S Al-Mezaine
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

8.  Patterns of uveitis at the Apex Institute for Eye Care in India: Results from a prospectively enrolled patient data base (2011-2013).

Authors:  Pradeep Venkatesh; Varun Gogia; Bhavin Shah; Shikha Gupta; Pradeep Sagar; Satpal Garg
Journal:  Int Ophthalmol       Date:  2015-09-25       Impact factor: 2.031

9.  Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.

Authors:  Muhammad A Ahad; Tom Missotten; Atiyeh Abdallah; Penny A Lympany; Susan Lightman
Journal:  Mol Vis       Date:  2007-03-23       Impact factor: 2.367

10.  Choroidal assessment in idiopathic panuveitis using optical coherence tomography.

Authors:  Michael Karampelas; Dawn A Sim; Pearse A Keane; Javier Zarranz-Ventura; Praveen J Patel; Adnan Tufail; Mark Westcott; Richard Lee; Carlos E Pavesio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.